Fang Tian

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, United States

Disclosure information not submitted.

Presentation(s):

• 1G-03 - Empirical Validation of Negative Control Outcomes for Detecting Residual Confounding in Pharmacoepidemiology: A Real-World Data Application

  Sunday, August 24, 2025
  11:00 AM - 11:15 AM ET

• 4G-05 - Assessing U-Comparability of Negative Controls Using Proxy Variables for Unmeasured Confounders: A Simulation Study

  Monday, August 25, 2025
  5:15 PM - 5:30 PM ET